Ads
related to: central nervous system
Search results
Study reveals racial disparities in diagnosis and drug use for dementia symptoms
Medical Xpress· 13 hours agoWhite and Hispanic people with these diagnoses were also most likely to be prescribed central...
Single-Cell Multi-Omics Analysis of IASO Bio's Equecabtagene Autoleucel in the Treatment of...
WROC Rochester· 4 days agoOn May 10, 2024, the impactful international academic journal, Science Immunology, a sub-journal of...
Christina Applegate reveals past struggle with an eating disorder: ‘I just deprived myself of food...
CNN via Yahoo News· 7 hours agoChristina Applegate spoke for the first time about her once-private struggle with an eating disorder...
Untreated hypothyroidism: Effects and more
Medical News Today· 5 days agoWithout treatment, hypothyroidism can lead to various medical issues, such as heart and kidney problems, nerve issues, or goiter. Low thyroid hormone...
Combination Therapy Holds Promise for Pancreatic Cancer Treatment: A Milestone Collaboration Between...
NewMediaWire via Yahoo Finance· 6 days agoFREMONT, CA - (NewMediaWire) - May 09, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a...
First West Nile virus-infected mosquito reported in North Texas
NBC Dallas Fort Worth· 9 hours agoThe first mosquito positive for West Nile virus this season was confirmed in North Texas on Tuesday...
Seelos Therapeutics Announces 1-for-8 Reverse Stock Split
FOX 59 Indianapolis· 14 hours agoSeelos Therapeutics, Inc. (Nasdaq: SEEL) ("Seelos" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders ...
Supernus Pharmaceuticals Reports Mixed Q1 2024 Results Amidst Strategic Shifts and Pipeline ...
GuruFocus.com via Yahoo Finance· 5 days agoTotal Revenue: Reported at $143.6 million, falling short of the estimated $145.83 million. Net Income: Reached $0.1 million, significantly below the estimated $20.73 million. Earnings Per Share ...
Catalyst's New CEO Has Big Ideas For The Small Biotech
Investor's Business Daily· 5 days agoCatalyst Pharmaceuticals' new Chief Executive, Richard Daly, is no stranger to working at big...
Pulmatrix Announces First Quarter 2024 Financial Results and Provides Corporate Update
FOX 4 Kansas City· 5 days ago$16.3 million in cash and cash equivalents at the end of Q1 2024 providing projected cash runway into Q1 2026 Third amendment made in Q1 to Cipla partnership results in the wind down of the ...
